AVGO insider Form 4: director sale of 800 Broadcom shares at $331.14

Q: At what price were the Broadcom (AVGO) shares sold in this insider trade?

The 800 Broadcom (AVGO) shares were sold at a price of $331.14 per share, as disclosed in the Form 4 filing.

Q: How many Broadcom (AVGO) shares does the insider own after the reported sale?

Following the sale, the reporting person beneficially owns 21,382 Broadcom shares, which includes 1,602 restricted stock units.

Q: What is the relationship of the reporting person to Broadcom (AVGO)?

The reporting person is identified in the filing as a Director of Broadcom Inc. (AVGO), with the Form 4 marked as filed by one reporting person.

Q: Does this Broadcom (AVGO) Form 4 involve any derivative securities?

The provided excerpt shows no transactions in derivative securities in Table II, focusing instead on the sale of common stock in Table I.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Broadcom Inc. (AVGO) director reports planned stock sale. A Broadcom director reported selling 800 shares of common stock on 11/14/2025 at a price of $331.14 per share in an open-market transaction coded as a sale. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 9, 2025, which is designed to allow trades according to preset instructions. After this sale, the reporting person beneficially owns 21,382 Broadcom shares, including 1,602 restricted stock units.

Insider Trade Summary

Net Seller: 800 shares

Net Sell 1 txn

Insider PAGE JUSTINE

Role Director

Sold 800 shs ($265K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $0.001 par value	800	$331.14	$265K

Holdings After Transaction: Common Stock, $0.001 par value — 21,382 shares (Direct)

Footnotes (2)

F1. Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2025.
F2. Includes 1,602 restricted stock units.

FAQ

What insider transaction did Broadcom (AVGO) report in this Form 4?

A Broadcom Inc. (AVGO) director reported an open-market sale of 800 shares of Broadcom common stock on 11/14/2025, classified under transaction code S for a sale.

At what price were the Broadcom (AVGO) shares sold in this insider trade?

The 800 Broadcom (AVGO) shares were sold at a price of $331.14 per share, as disclosed in the Form 4 filing.

Was the Broadcom (AVGO) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states that the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

How many Broadcom (AVGO) shares does the insider own after the reported sale?

Following the sale, the reporting person beneficially owns 21,382 Broadcom shares, which includes 1,602 restricted stock units.

What is the relationship of the reporting person to Broadcom (AVGO)?

The reporting person is identified in the filing as a Director of Broadcom Inc. (AVGO), with the Form 4 marked as filed by one reporting person.

Does this Broadcom (AVGO) Form 4 involve any derivative securities?

The provided excerpt shows no transactions in derivative securities in Table II, focusing instead on the sale of common stock in Table I.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/18/2025 - 06:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PAGE JUSTINE

(Last)

(First)

(Middle)

C/O BROADCOM INC.

3421 HILLVIEW AVENUE

(Street)

PALO ALTO

94304

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Broadcom Inc. [ AVGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.001 par value	11/14/2025		S⁽¹⁾		800	D	$331.14	21,382⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2025.

2. Includes 1,602 restricted stock units.

Remarks:

	/s/ Noelle Matteson, Attorney-in-Fact for Justine F. Page	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR